CSIMarket
 
Assertio Holdings inc   (NASDAQ: ASRT)
 

Assertio Holdings Inc's Customers Performance

ASRT



 
ASRT's Source of Revenues During the corresponding time, Assertio Holdings Inc saw a revenue deteriorated by -62.5 % year on year, sequentially revenue fell by -26.66 %. While revenue at the Assertio Holdings Inc 's corporate clients

List of ASRT Customers




for the same period Assertio Holdings Inc revnue deteriorated by -62.5 % year on year, sequentially revenue fell by -26.66 %.

List of ASRT Customers

Assertio Holdings Inc's Business Units
Total product sales net    89.58 % of total Revenue
ROLVEDON    4.96 % of total Revenue
INDOCIN products    34.69 % of total Revenue
Sympazan    25.97 % of total Revenue
SPRIX    13.79 % of total Revenue
Other products    10.16 % of total Revenue
Royalty revenue    4.38 % of total Revenue
Other revenue    6.04 % of total Revenue
Product sales net    89.58 % of total Revenue
CAMBIA Canada    4.03 % of total Revenue






Assertio Holdings Inc's Comment on Sales, Marketing and Customers



The company operates in the pharmaceutical market, providing drug products including ROLVEDON, INDOCIN suppositories, and Cambia. It depends on third-party manufacturers and suppliers for these products. The company faces competition from generic and biosimilar versions, which impacts its business. FDA regulations influence the timing of biosimilar applications and approvals for ROLVEDON. The company maintains supply agreements with manufacturers for ROLVEDON and INDOCIN, with recent renegotiations prompted by supplier price increase requests.





Assertio Holdings Inc’s Comment on Sales, Marketing and Customers


The company operates in the pharmaceutical market, providing drug products including ROLVEDON, INDOCIN suppositories, and Cambia. It depends on third-party manufacturers and suppliers for these products. The company faces competition from generic and biosimilar versions, which impacts its business. FDA regulations influence the timing of biosimilar applications and approvals for ROLVEDON. The company maintains supply agreements with manufacturers for ROLVEDON and INDOCIN, with recent renegotiations prompted by supplier price increase requests.








ASRT's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Assertio Holdings inc 151.20 102.16 -35.69 53
SUBTOTAL 0.00 0.00 0.00 -

Sources: Assertio Holdings inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Assertio Holdings inc’s corporate clients.
For your research, we’ve provided 9 tables on Assertio Holdings inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.